NimbleRx Revenue and Competitors

Location

$60.1M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • NimbleRx's estimated annual revenue is currently $35.2M per year.(i)
  • NimbleRx's estimated revenue per employee is $251,250
  • NimbleRx's total funding is $60.1M.

Employee Data

  • NimbleRx has 140 Employees.(i)
  • NimbleRx grew their employee count by 40% last year.

NimbleRx's People

NameTitleEmail/Phone
1
VP, Business DevelopmentReveal Email/Phone
2
Head ProductReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Chief Technology OfficerReveal Email/Phone
5
Pharmacy Hub ManagerReveal Email/Phone
6
Lifecycle Marketing ManagerReveal Email/Phone
7
Senior Manager, Client PartnersReveal Email/Phone
8
Manager, Data AnalyticsReveal Email/Phone
9
Product ManagerReveal Email/Phone
10
Senior Operations ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.1M25-57%$60.6MN/A
Add Company

What Is NimbleRx?

Nimble is a technology company that enables people to live their best lives. We do this by empowering local and national pharmacies and in turn improve access to medications for customers. We started by getting medications to those who need them, but we envision a world where managing your health is easier and leads to happier, fuller lives and thriving local businesses.

keywords:Mobile, Healthcare, Same Day Delivery

$60.1M

Total Funding

140

Number of Employees

$35.2M

Revenue (est)

40%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NimbleRx News

2020-08-21 - Uber Health Launches Contactless Prescription Delivery in Seattle and Dallas

What You Should Know: – NimbleRx and Uber Health launches contactless prescription delivery from pharmacies in Seattle, WA, and Dallas, TX, and soon, other parts of the country. – Following the initial launches in Seattle and Dallas, Nimble and Uber Health are already working to expand the par ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$36.2M14526%N/A
#2
$25.7M146N/AN/A
#3
$47.2M1488%N/A
#4
$23.9M150-8%N/A
#5
$23.4M1527%N/A